Jeffrey R. Colin concentrates his practice on complex patent litigation with a focus on pharmaceuticals, chemicals, biotechnology, biologics, and medical devices. Jeffrey has experience litigating patent infringement cases arising under the Hatch-Waxman Act and pertaining to drugs for treating various diseases including benign prostatic hyperplasia, migraines, high triglycerides, acne, cold/flu, attention deficit hyperactivity disorder, irritable bowel syndrome, and hepatic encephalopathy. Jeffrey has participated in all stages of litigation from pre-suit through appeal, including drafting pleadings and motions, overseeing complex e-discovery, preparing contentions in patent infringement cases, taking and defending fact and expert depositions, drafting expert reports, drafting briefs for Markman, preliminary injunction, summary judgment, trial and appeal, formulating litigation strategy, and overseeing day-to-day case management.
Jeffrey has also provided general intellectual property counseling to clients, conducted due diligence analyses, and drafted freedom to operate opinions.
- Patent litigation
- ANDA Hatch-Waxman litigation
- General IP counseling, licensing, due diligence, and opinions
- Trade secret litigation